Inovio Pharmaceuticals Inc (INO)
4.07
+0.01
(+0.25%)
USD |
NASDAQ |
Nov 22, 16:00
4.08
+0.01
(+0.25%)
After-Hours: 20:00
Inovio Pharmaceuticals Free Cash Flow: -111.18M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -111.18M |
| June 30, 2024 | -112.84M |
| March 31, 2024 | -116.52M |
| December 31, 2023 | -124.69M |
| September 30, 2023 | -134.92M |
| June 30, 2023 | -173.36M |
| March 31, 2023 | -192.26M |
| December 31, 2022 | -217.18M |
| September 30, 2022 | -219.21M |
| June 30, 2022 | -198.32M |
| March 31, 2022 | -225.74M |
| December 31, 2021 | -216.94M |
| September 30, 2021 | -230.58M |
| June 30, 2021 | -258.46M |
| March 31, 2021 | -206.98M |
| December 31, 2020 | -179.50M |
| September 30, 2020 | -141.17M |
| June 30, 2020 | -94.50M |
| March 31, 2020 | -91.32M |
| December 31, 2019 | -98.84M |
| September 30, 2019 | -102.61M |
| June 30, 2019 | -99.54M |
| March 31, 2019 | -95.02M |
| December 31, 2018 | -75.64M |
| September 30, 2018 | -72.84M |
| Date | Value |
|---|---|
| June 30, 2018 | -68.94M |
| March 31, 2018 | -71.21M |
| December 31, 2017 | -73.50M |
| September 30, 2017 | -73.65M |
| June 30, 2017 | -71.86M |
| March 31, 2017 | -66.09M |
| December 31, 2016 | -66.49M |
| September 30, 2016 | -59.12M |
| June 30, 2016 | -25.36M |
| March 31, 2016 | -19.05M |
| December 31, 2015 | -15.22M |
| September 30, 2015 | -15.87M |
| June 30, 2015 | -38.87M |
| March 31, 2015 | -38.06M |
| December 31, 2014 | -31.20M |
| September 30, 2014 | -22.01M |
| June 30, 2014 | -19.53M |
| March 31, 2014 | -16.13M |
| December 31, 2013 | -15.56M |
| September 30, 2013 | -22.05M |
| June 30, 2013 | -22.21M |
| March 31, 2013 | -22.18M |
| December 31, 2012 | -22.55M |
| September 30, 2012 | -21.59M |
| June 30, 2012 | -20.82M |
Free Cash Flow Range, Past 5 Years
-258.46M
Minimum
Jun 2021
-91.32M
Maximum
Mar 2020
-167.23M
Average
-176.43M
Median
Free Cash Flow Benchmarks
| Novavax Inc | -112.35M |
| Baxter International Inc | 391.00M |
| AIM ImmunoTech Inc | -21.33M |
| Protalix BioTherapeutics Inc | 7.171M |
| Armata Pharmaceuticals Inc | -42.09M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.44M |
| Cash from Investing (Quarterly) | 14.08M |
| Cash from Financing (Quarterly) | 0.6606M |
| Free Cash Flow Per Share (Quarterly) | -0.9752 |
| Free Cash Flow Yield | -107.8% |